This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...